Medication info
Glimepiride Tablet (Glimepiride)

Glimepiride Tablet (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Kims Pharmaceutical Co., Ltd.
Appearance
Green oblong tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201907571 · Approved 2019.10.30 · Insurance code 059600340

Summary

Main use
Improvement of glycemic control in type 2 diabetes
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medicine is taken orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Starting dose and dose titration For patients who have not previously received drug therapy, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses above 4 mg, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering drug to this medicine There is no precise dose equivalence between this medicine and other oral blood glucose-lowering drugs. When switching from another oral blood glucose-lowering drug to this medicine, it is advisable to follow the method described under Starting dose. That is, start treatment with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous drug should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur after initial successful treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate treatment and follow-up by a physician and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal; start insulin at a low dose and increase it approximately once a week according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy with metformin and other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant use of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Kims Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes

  • Abnormal blood sugar control in type 2 diabetes patients
View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes, assisting alongside dietary and exercise therapy. It can be used alone and may also be administered in combination with other oral hypoglycemic agents or insulin, depending on the case. Particularly, when blood sugar control is insufficient with sulfonylureas or monotherapy with metformin, the effect can be enhanced by combining it with metformin. This helps manage blood sugar more effectively and improves the patient's health.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medicine is taken orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Starting dose and dose titration For patients who have not previously received drug therapy, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses above 4 mg, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering drug to this medicine There is no precise dose equivalence between this medicine and other oral blood glucose-lowering drugs. When switching from another oral blood glucose-lowering drug to this medicine, it is advisable to follow the method described under Starting dose. That is, start treatment with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous drug should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur after initial successful treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate treatment and follow-up by a physician and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal; start insulin at a low dose and increase it approximately once a week according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy with metformin and other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant use of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with type 1 diabetes who are insulin-dependent, or in cases of diabetic ketoacidosis or coma. Patients who have had an allergic reaction to this medication or its components, or similar classes of drugs should not be administered this medication. It is recommended that patients with severe liver or kidney impairment do not use this medication and switch to insulin therapy instead. Women who are pregnant or breastfeeding should also avoid this medication, and if necessary, switch to insulin therapy. Insulin therapy is recommended for patients with severe infections, before and after surgery, or severe trauma instead of this medication. Caution should be exercised if gastrointestinal disorders such as diarrhea or vomiting occur, as this medication may increase the risk of hypoglycemia. During the first week of taking this medication, the risk of hypoglycemia is high, so blood sugar levels should be closely monitored, especially in the elderly or patients with irregular meals or poor nutritional status. Patients who frequently consume alcohol or have weakened renal or liver function may also be sensitive to the effects of this medication. When taking other medications concurrently, interactions may lead to changes in blood sugar control; therefore, consultation with a physician or pharmacist is necessary. This medication can cause hypoglycemia, with symptoms including headache, severe hunger, nausea, fatigue, confusion, drowsiness, reduced consciousness, etc., and if symptoms occur, sugar should be immediately ingested. In severe cases, emergency treatment at a hospital may be required, so immediate medical attention should be sought if symptoms are severe. It is important to manage blood sugar properly through regular meals and exercise while taking this medication. Women who are pregnant or breastfeeding should choose other treatments to avoid harming the fetus or newborn. The safety and efficacy of this medication have not been established in children under 18 years of age and should not be used. In the elderly, renal function may be diminished, so the dosage should be adjusted, and administration should be cautious. In the event of an overdose, the risk of hypoglycemia is significantly increased, requiring immediate medical treatment, which may include inducing vomiting, gastric lavage, or intravenous glucose.

Side effects

  • Hypoglycemia
  • headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep
  • sleep disorders
  • anxiety
  • aggression
Show 67 more
  • decreased concentration
  • decreased agility or activity
  • depression
  • confusion
  • speech abnormalities
  • aphasia
  • visual disturbances
  • tremors
  • partial paralysis
  • sensory abnormalities
  • dizziness
  • weakness
  • loss of self-control
  • transient mental confusion
  • seizures
  • drowsiness
  • loss of consciousness
  • coma
  • shallow breathing
  • bradycardia
  • sweating
  • cold and moist skin
  • tachycardia
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis
  • blurred vision
  • fullness in the upper abdomen
  • pressure sensation
  • abdominal pain
  • diarrhea
  • increased liver enzymes
  • liver dysfunction
  • bile secretion disorders
  • jaundice
  • hepatitis
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • anemia
  • agranulocytosis
  • pancytopenia
  • itching
  • urticaria
  • rash
  • dyspnea
  • hypotension
  • shock
  • anaphylaxis
  • angioedema
  • skin and mucous membrane syndrome
  • allergic vasculitis
  • photosensitivity reactions of the skin
  • decreased serum sodium concentration
  • taste disorders
  • hair loss
  • weight gain
  • dizziness
  • liver dysfunction
  • abdominal pain
  • arthralgia
  • indigestion
  • facial swelling
  • erectile dysfunction
  • facial flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering. The ideal storage temperature is between 1 to 30 degrees Celsius at room temperature, which helps maintain the medication’s effectiveness over time.

Appearance and packaging

Appearance

Green oblong tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.